Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marrero AM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bensreti H; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA., Alhamad DW; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA., Gonzalez AM; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA., Pizarro-Mondesir M; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA., Bollag WB; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, GA, USA.; Charlie Norwood VA Medical Center, Augusta, GA, USA., Isales CM; Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.; Department of Orthopaedic Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA.; Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA., McGee-Lawrence ME; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, USA. mmcgeelawrence@augusta.edu.; Department of Orthopaedic Surgery, Medical College of Georgia, Augusta University, Augusta, GA, USA. mmcgeelawrence@augusta.edu.
Publikováno v:
Current osteoporosis reports [Curr Osteoporos Rep] 2023 Feb; Vol. 21 (1), pp. 32-44. Date of Electronic Publication: 2022 Dec 24.
Autor:
Arikawa AY; Department of Nutrition and Dietetics, University of North Florida, Jacksonville. Electronic address: andrea.arikawa@unf.edu., Ross J; Department of Nutrition and Dietetics, University of North Florida, Jacksonville., Wright L; Department of Nutrition and Dietetics, University of North Florida, Jacksonville., Elmore M; Department of Nutrition and Dietetics, University of North Florida, Jacksonville., Gonzalez AM; Department of Nutrition and Dietetics, University of North Florida, Jacksonville., Wallace TC; Department of Nutrition and Food Studies, George Mason University, Washington, DC.
Publikováno v:
Journal of the Academy of Nutrition and Dietetics [J Acad Nutr Diet] 2021 Jul; Vol. 121 (7), pp. 1231-1241. Date of Electronic Publication: 2020 Nov 03.
Autor:
Guix FX; Molecular Neuropathology Unit, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain fguix@cbm.csic.es fguixrafols@gmail.com., Capitán AM; Molecular Neuropathology Unit, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain., Casadomé-Perales Á; Molecular Neuropathology Unit, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain., Palomares-Pérez I; Molecular Neuropathology Unit, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain., López Del Castillo I; Molecular Neuropathology Unit, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain., Miguel V; Molecular Pathophysiology of Fibrosis, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain., Goedeke L; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, USA.; Integrative Cell Signalling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA., Martín MG; Instituto de Investigación Médica Mercedes y Martín Ferreyra (INIMEC)-Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)-Universidad Nacional de Córdoba (UNC), Córdoba, Argentina., Lamas S; Molecular Pathophysiology of Fibrosis, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain., Peinado H; Microenvironment and Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Fernández-Hernando C; Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, CT, USA.; Integrative Cell Signalling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA., Dotti CG; Molecular Neuropathology Unit, Physiological and Pathological Processes Program, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)/Universidad Autónoma de Madrid (UAM), Madrid, Spain cdotti@cbm.csic.es.
Publikováno v:
Life science alliance [Life Sci Alliance] 2021 Jun 28; Vol. 4 (8). Date of Electronic Publication: 2021 Jun 28 (Print Publication: 2021).
Autor:
Harper J; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland. harperja@medimmune.com., Lloyd C; Antibody Discovery and Protein Engineering, MedImmune, Ltd, Cambridge, United Kingdom., Dimasi N; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland., Toader D; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland., Marwood R; Antibody Discovery and Protein Engineering, MedImmune, Ltd, Cambridge, United Kingdom., Lewis L; Antibody Discovery and Protein Engineering, MedImmune, Ltd, Cambridge, United Kingdom., Bannister D; Antibody Discovery and Protein Engineering, MedImmune, Ltd, Cambridge, United Kingdom., Jovanovic J; Antibody Discovery and Protein Engineering, MedImmune, Ltd, Cambridge, United Kingdom., Fleming R; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland., D'Hooge F; Spirogen, London, United Kingdom., Mao S; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Marrero AM; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Korade M 3rd; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Strout P; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Xu L; Antibody Discovery and Protein Engineering, MedImmune, LLC, Gaithersburg, Maryland., Chen C; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Wetzel L; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Breen S; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., van Vlerken-Ysla L; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Jalla S; Project Management, MedImmune, LLC, Gaithersburg, Maryland., Rebelatto M; Pathology, MedImmune, LLC, Gaithersburg, Maryland., Zhong H; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Hurt EM; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Hinrichs MJ; Biologics Safety Assessment, MedImmune, LLC, Gaithersburg, Maryland., Huang K; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Howard PW; Spirogen, London, United Kingdom., Tice DA; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Hollingsworth RE; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Herbst R; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland., Kamal A; Oncology Research, MedImmune, LLC, Gaithersburg, Maryland.; Ferring Pharmaceuticals, San Diego, California.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2017 Aug; Vol. 16 (8), pp. 1576-1587. Date of Electronic Publication: 2017 May 18.
Autor:
Ferry-Galow KV; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD. Electronic address: Katherine.FerryGalow@nih.gov., Makhlouf HR; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, Rockville, MD., Wilsker DF; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD., Lawrence SM; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD., Pfister TD; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD., Marrero AM; MedImmune LLC, Gaithersburg, MD., Bigelow KM; Johns Hopkins School of Medicine, Department of Pharmacology and Molecular Sciences, Baltimore, MD., Yutzy WH; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD., Ji JJ; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD., Butcher DO; Pathology/Histotechnology Laboratory, Animal Sciences Program, Leidos Biomedical Research, Frederick National Laboratories, Frederick, MD., Gouker BA; Pathology/Histotechnology Laboratory, Animal Sciences Program, Leidos Biomedical Research, Frederick National Laboratories, Frederick, MD., Kummar S; Stanford University School of Medicine, Department of Oncology, Stanford, CA., Chen AP; NCI/DCTD-Early Clinical Trials Development Program, Bethesda, MD., Kinders RJ; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD., Parchment RE; Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.
Publikováno v:
Seminars in oncology [Semin Oncol] 2016 Aug; Vol. 43 (4), pp. 484-91. Date of Electronic Publication: 2016 Jun 15.
Autor:
LoRusso PM; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. geoffrey_shapiro@dfci.harvard.edu., Li J; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Burger A; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Heilbrun LK; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Sausville EA; University of Maryland Greenebaum Cancer Center, Baltimore, Maryland., Boerner SA; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Smith D; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Pilat MJ; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. Wayne State University, Detroit, Michigan., Zhang J; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Tolaney SM; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Cleary JM; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Rubinstein L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Boerner JL; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Bowditch A; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Cai D; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Bell T; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Wolanski A; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Marrero AM; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Zhang Y; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Ji J; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Ferry-Galow K; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Kinders RJ; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Parchment RE; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Shapiro GI; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Jul 01; Vol. 22 (13), pp. 3227-37. Date of Electronic Publication: 2016 Feb 03.